Novo vet Uli Stilz settles in at Flagship; Revolution Medicines welcomes commercial exec

Thomas Lampron formally announced on LinkedIn this week that he is 'thrilled to join the powerhouse team at Revolution Medicines' as VP, global commercial pancreas lead, ending a 13-year career with Merck.

Raccontata daendpoints.news